Ironwood Pharmaceuticals
IRWD
IRWD
250 hedge funds and large institutions have $2.03B invested in Ironwood Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 94 increasing their positions, 88 reducing their positions, and 22 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
250
Holders Change
+5
Holders Change %
+2.04%
% of All Funds
4.03%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
29
Increased
94
Reduced
88
Closed
22
Calls
$1.6M
Puts
$28K
Net Calls
+$1.57M
Net Calls Change
+$977K
Top Buyers
| 1 |
Millennium Management
New York
|
+$27.1M |
| 2 |
Two Sigma Investments
New York
|
+$17.6M |
| 3 |
JPMorgan Chase & Co
New York
|
+$17.4M |
| 4 |
Two Sigma Advisers
New York
|
+$14.9M |
| 5 |
BlackRock
New York
|
+$9.95M |
Top Sellers
| 1 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
-$57.5M |
| 2 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$15.7M |
| 3 |
Renaissance Technologies
New York
|
-$12.4M |
| 4 |
BM
Bridger Management
New York
|
-$9.49M |
| 5 |
Westfield Capital Management
Boston,
Massachusetts
|
-$8.42M |
